Exploring Noncardiac Surgical Needs From Infancy to Adulthood in Patients With Congenital Heart Disease

A Rebecca L Hamilton1, Kirsten C Odegard2, Koichi Yuki2

  • 1Division of Cardiac Anesthesia, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital, Boston, MA; Department of Anaesthesia, Harvard Medical School, Boston, MA; Department of Cell and Molecular Biology, Karolinska Institute, Stockholm, Sweden.

Insights

Patients with congenital heart disease (CHD) require increasing noncardiac surgery throughout life. Needs shift from ear, nose, and throat procedures in childhood to orthopedic and dental surgeries in adolescence.

Area of Science:

  • Pediatric Cardiology
  • Surgical Outcomes
  • Congenital Heart Disease Management

Background:

  • Rising life expectancy for congenital heart disease (CHD) patients leads to increased noncardiac surgical needs in pediatric and adolescent populations.
  • Understanding the evolving surgical landscape for CHD patients is crucial for optimizing perioperative care.

Purpose of the Study:

  • To map the spectrum of noncardiac surgical requirements across the lifespan of patients with CHD.
  • To analyze trends in noncardiac surgical needs and procedures in children and adolescents with CHD over time.

Main Methods:

  • Retrospective review of 3,011 noncardiac surgical procedures performed on patients with CHD between 2008 and 2014.
  • Data collected included patient demographics, CHD diagnosis, surgical procedures, and clinical parameters like cardiac function.
  • Patients were grouped by cardiac diagnosis for comparative analysis.

Main Results:

  • The most frequent CHD diagnoses were patent ductus arteriosus, ventricular septal defects, and patent foramen ovale.
  • Ear, nose, and throat (20%), general surgery (14%), and radiology (11%) were the most common procedures.
  • Intraoperative events occurred in 16.2% of cases, with higher rates in single-ventricle physiology patients (30.7%).

Conclusions:

  • Noncardiac surgical burden is higher in younger age groups.
  • Surgical needs evolve, with ear, nose, and throat and general surgery common in young children, and orthopedic and dental procedures increasing in adolescence.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
22
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
28
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
37
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
25
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
16
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
19